Swiss National Bank
CRBU icon

Swiss National Bank’s Caribou Biosciences CRBU Stock Holding History

Swiss National Bank’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-105,300
Closed -$559K – 2619
2023
Q1 		$559K Sell
105,300
-12,200
-10% -$76K ﹤0.01% 2496
2022
Q4 		$738K Buy
117,500
+3,100
+3% +$27.6K ﹤0.01% 2474
2022
Q3 		$1.21M Hold
114,400
– – ﹤0.01% 2227
2022
Q2 		$621K Buy
114,400
+57,400
+101% +$439K ﹤0.01% 2556
2022
Q1 		$523K Buy
57,000
+4,200
+8% +$44.3K ﹤0.01% 2598
2021
Q4 		$797K Buy
+52,800
New +$1.03M ﹤0.01% 2549

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Swiss National Bank's CRBU Position: Q2 2023 in Review

Swiss National Bank sold out of Caribou Biosciences (CRBU) in Q2 2023, closing a stake of 105,300 shares — an estimated $559K sold.

Swiss National Bank first reported a position in CRBU in Q4 2021 and held it in 6 quarters. The position peaked at $1.21M in Q3 2022. 121 funds tracked by Wall St. Rank hold CRBU as of Q2 2023.

  • Swiss National Bank reported no remaining Caribou Biosciences position as of Q2 2023 after selling out during the quarter.
  • Swiss National Bank sold 105,300 Caribou Biosciences shares in Q2 2023, an estimated $559K.
  • Swiss National Bank first reported a position in Caribou Biosciences in Q4 2021 and held it in 6 quarters.
  • Swiss National Bank's Caribou Biosciences position peaked at $1.21M in Q3 2022.
  • 121 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2023.

Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.